Sunbed tanning
RadiationInvention groups undergo a 12-week tanning protocol that follows Health Canada's RED Act
NCT Number: NCT02334592
Health Canada's Radiation Emitting Devices (RED) Act provides exposure time guidelines for sunbed use. These guidelines are intended to protect sunbed users from overexposure to UV radiation. Overexposure is defined as "exposure that exceeds the amount needed for vitamin D production and could lead to skin or eye damage. Acute overexposure induces sunburn." However, the effect of the recommended time exposure schedule on serum 25(OH)D response has not been characterized. Further, it is unknown if the maximum time exposures are required to reach and/or maintain optimal 25(OH)D levels. The aim of the current study is to characterize serum 25(OH)D response to regular sunbed use following the time exposure schedule recommended by Health Canada.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Invention groups undergo a 12-week tanning protocol that follows Health Canada's RED Act
Time frame: 12 weeks
Time frame: 12 weeks
Time frame: 12 weeks
Vitamin D Society
Other
The Impact of Health Canada's Sunbed Exposure Time Guidelines on Serum 25(OH)D Concentrations
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06945419
Body Weight, Body Weight Changes
Daytona Beach, Florida, United States
View Trial DetailsNCT05533372
Arthritis, Arthritis, Rheumatoid
Lenexa, Kansas, United States
View Trial DetailsNCT06916078
Digestive System Diseases, Healthy
Miami, Florida, United States
View Trial DetailsNCT05443438
Healthy
Stillwater, Oklahoma, United States
View Trial Details